Jeremy Chataway

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

Stephen Sawcer, Hywel B. Jones, Robert Feakes et al. · Nature Genetics · 1996 · 646 citations

Life Sciences, Genetics, Molecular Genetics +10

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

Jeremy Chataway, Nadine Schuerer, Ali Alsanousi et al. · The Lancet · 2014 · 448 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

Alison Halliday, Richard Bulbulia, Leo H. Bonati et al. · The Lancet · 2021 · 312 citations · Full text

Medicine, Neurosurgery, Surgery +17

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial

Raju Kapoor, J Furby, Thomas Hayton et al. · The Lancet Neurology · 2010 · 265 citations

Medicine, Neurology, Pharmacotherapy +14

Psychological distress after stroke and aphasia: the first six months

Katerina Hilari, Sarah Northcott, Penny Roy et al. · Clinical Rehabilitation · 2010 · 261 citations

Health Professions, Neurology, Psychology +17